in , ,

PDS Biotechnology Signs Cooperative Research and Development Agreement with National Cancer Institute

PDS Biotechnology Corporation announced that it has entered into a Cooperative Research and Development Agreement with the National Cancer Institute (NCI) for the development of the PDS0101 HPV cancer immunotherapy in combination with other immune-modulating agents as a potential treatment for advanced HPV-related cancers. (apnews)

This post was created with our nice and easy submission form. Create your post!

What do you think?

68 points
Upvote Downvote

Posted by registerCoop

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

0

Comments

0 comments

Co-op raises £300m for Fairtrade farmers with top-earning bond

Co-op bill important to restore trust